A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Abroad (travel likely)RecruitingPHASE3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Breast Cancer
Locations
- Research Site, Largo, Florida, United States
- Research Site, Fort Wayne, Indiana, United States
- Research Site, Omaha, Nebraska, United States
- Research Site, New York, New York, United States
- Research Site, Houston, Texas, United States
- Research Site, Puyallup, Washington, United States
- Research Site, Beijing, China
- Research Site, Changsha, China
- Research Site, Guangzhou, China
- Research Site, Linyi, China
- Research Site, Shandong, China
- Research Site, Wuhan, China
- Research Site, Zhengzhou, China
- Research Site, Clermont-Ferrand, France
- Research Site, La Roche-sur-Yon, France
- Research Site, Montpellier, France
- Research Site, Paris, France
- Research Site, Pierre-Bénite, France
- Research Site, Aviano, Italy
- Research Site, Florence, Italy
- Research Site, Meldola, Italy
- Research Site, Milan, Italy
- Research Site, Naples, Italy
- Research Site, Roma, Italy
- Research Site, Bukgu, South Korea
- Research Site, Goyang-si, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, A Coruña, Spain
- Research Site, Barcelona, Spain
- Research Site, Granada, Spain
- Research Site, Madrid, Spain
- Research Site, Madrid, Spain
- Research Site, Madrid, Spain
- Research Site, Seville, Spain
- Research Site, Valencia, Spain